The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
Open accessAbstract
A clear understanding of the genetic basis of antibiotic resistance in Mycobacterium tuberculosis is required to accelerate the development of rapid drug susceptibility testing methods based on genetic sequence. Raw genotype–phenotype correlation data were extracted as part of a comprehensive systematic review to develop a standardised analytical approach for interpreting resistance associated mutations for rifampicin, isoniazid, ofloxacin/levofloxacin, moxifloxacin, amikacin, kanamycin, capreomycin, streptomycin, ethionamide/prothionamide and pyrazinamide. Mutation frequencies in resistant and susceptible isolates were calculated, together with novel statistical measures to classify mutations as high, moderate, minimal or indeterminate confidence for predicting resistance. We identified 286 confidence-graded mutations associated with resistance. Compared to phenotypic methods, sensitivity (95% CI) for rifampicin was 90.3% (89.6–90.9%), while for isoniazid it was 78.2% (77.4–79.0%) and their specificities were 96.3% (95.7–96.8%) and 94.4% (93.1–95.5%), respectively. For second-line drugs, sensitivity varied from 67.4% (64.1–70.6%) for capreomycin to 88.2% (85.1–90.9%) for moxifloxacin, with specificity ranging from 90.0% (87.1–92.5%) for moxifloxacin to 99.5% (99.0–99.8%) for amikacin. This study provides a standardised and comprehensive approach for the interpretation of mutations as predictors of M. tuberculosis drug-resistant phenotypes. These data have implications for the clinical interpretation of molecular diagnostics and next-generation sequencing as well as efficient individualised therapy for patients with drug-resistant tuberculosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Statistics Notes: Diagnostic tests 2: predictive values
Altman, D. G., & Bland, J. M. (1994) · BMJ · doi:10.1136/bmj.309.6947.102 · Cited by 1,711
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Woods, G. L., Brown‐Elliott, B. A., Conville, P. S., Desmond, E. P., Hall, G. S., Lin, G., Pfyffer, G. E., Ridderhof, J. C., Siddiqi, S. H., Wallace, R. J., et al. (2011) · Cited by 1,136
Toward Evidence-Based Medical Statistics. 2: The Bayes Factor
Goodman, S. N. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-12-199906150-00019 · Cited by 912
Refining clinical diagnosis with likelihood ratios
Grimes, D. A., & Schulz, K. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66422-7 · Cited by 828
(1969) · Europe PMC (PubMed Central) · Cited by 765
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Self-citationWalker, T. M., Kohl, T. A., Omar, S. V., Hedge, J., Del Ojo Elias, C., Bradley, P., Iqbal, Z., Feuerriegel, S., Niehaus, K. E., Wilson, D. J., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00062-6 · Cited by 638
Self-citationEllington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
Self-citationQUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W., Westwood, M. E., Mallett, S. V., Deeks, J. J., Reitsma, J. B., Leeflang, M., Sterne, J. A. C., & Bossuyt, P. M. (2011) · Data Archiving and Networked Services (DANS) · doi:10.1059/0003-4819-155-8-201110180-00009 · Cited by 601
Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., Becerra, M. C., Benedetti, A., Burgos, M., Centis, R., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001300 · Cited by 535
Self-citationRapid determination of anti-tuberculosis drug resistance from whole-genome sequences
Coll, F., McNerney, R., Preston, M. D., Guerra-Assunção, J. A., Warry, A., Hill-Cawthorne, G., Mallard, K., Nair, M., Miranda, A., Alves, A., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0164-0 · Cited by 420
Self-citationWorld Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Falzon, D., Schünemann, H. J., Harausz, E., González-Angulo, L., Lienhardt, C., Jaramillo, E., & Weyer, K. (2017) · European Respiratory Journal · doi:10.1183/13993003.02308-2016 · Cited by 420
Campbell, P. J., Morlock, G. P., Sikes, R. D., Dalton, T. L., Metchock, B., Starks, A. M., Hooks, D. P., Cowan, L. S., Plikaytis, B. B., & Posey, J. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01550-10 · Cited by 379
Self-citationBedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
Pym, A. S., Diacon, A. H., Tang, S.-J., Conradie, F., Danilovits, M., Chuchottaworn, C., Vasilyeva, I., Andries, K., Bakare, N., De Marez, T., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00724-2015 · Cited by 333
Zaunbrecher, M. A., Sikes, R. D., Metchock, B., Shinnick, T. M., & Posey, J. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907925106 · Cited by 330
Self-citationMigliori, G. B., Sotgiu, G., Gandhi, N. R., Falzon, D., DeRiemer, K., Centis, R., Hollm-Delgado, M.-G., Palmero, D., Pérez-Guzmán, C., Vargas, M. H., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00136312 · Cited by 251
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard
Van Deun, A., Aung, K. J. M., Bola, V., Lebeke, R., Hossain, M. A., de Rijk, W. B., Rigouts, L., Gumusboga, A., Torrea, G., & de Jong, B. C. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00553-13 · Cited by 241
Self-citationHayden, S. R., & Brown, M. D. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70346-x · Cited by 225
Safi, H., Lingaraju, S., Amin, A., Kim, S., Jones, M., Holmes, M., McNeil, M., Peterson, S. N., Chatterjee, D., Fleischmann, R., et al. (2013) · Nature Genetics · doi:10.1038/ng.2743 · Cited by 205
Self-citationRigouts, L., Gumusboga, M., de Rijk, W. B., Nduwamahoro, E., Uwizeye, C., de Jong, B., & Van Deun, A. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.02741-12 · Cited by 200
Self-citationMycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives
Schön, T., Miotto, P., Köser, C. U., Viveiros, M., Böttger, E., & Cambau, E. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.10.022 · Cited by 179
Self-citationBedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence
Pontali, E., Sotgiu, G., D’Ambrosio, L., Centis, R., & Migliori, G. B. (2016) · European Respiratory Journal · doi:10.1183/13993003.01891-2015 · Cited by 159
Practitioner's Guide to Using Research for Evidence-Based Practice
Rubin, A., & Bellamy, J. L. (2007) · Cited by 154
Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value
Farhat, M. R., Sultana, R., Iartchouk, O., Bozeman, S., Galagan, J. E., Sisk, P., Stolte, C., Nebenzahl-Guimaraes, H., Jacobson, K. R., Sloutsky, A., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2091oc · Cited by 145
Self-citationBoyko, E. J. (1994) · Medical Decision Making · doi:10.1177/0272989x9401400210 · Cited by 127
Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis
Borrell, S., & Gagneux, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03556.x · Cited by 116
Self-citationThe complex evolution of antibiotic resistance in Mycobacterium tuberculosis
da Fonseca, J. D., Knight, G. M., & McHugh, T. D. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.01.014 · Cited by 113
Interval likelihood ratios: Another advantage for the evidence-based diagnostician
Brown, M. D., & Reeves, M. J. (2003) · Annals of Emergency Medicine · doi:10.1067/mem.2003.274 · Cited by 109
Nebenzahl-Guimaraes, H., Jacobson, K. R., Farhat, M. R., & Murray, M. B. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt358 · Cited by 99
Self-citationSpecificgyrAgene mutations predict poor treatment outcome in MDR-TB
Rigouts, L., Coeck, N., Gumusboga, M., de Rijk, W. B., Aung, K. J. M., Hossain, M. A., Fissette, K., Rieder, H. L., Meehan, C. J., de Jong, B. C., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv360 · Cited by 89
Self-citationRahman, A., Sahrin, M., Afrin, S., Earley, K. T., Ahmed, S., Rahman, S. M. M., & Banu, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152694 · Cited by 85
Starks, A. M., Avilés, E., Cirillo, D. M., Denkinger, C. M., Dolinger, D. L., Emerson, C., Gallarda, J., Hanna, D. L., Kim, P. S., Liwski, R., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ610 · Cited by 81
Self-citationA silent mutation in mabA confers isoniazid resistance on M ycobacterium tuberculosis
Ando, H., Miyoshi‐Akiyama, T., Watanabe, S., & Kirikae, T. (2013) · Molecular Microbiology · doi:10.1111/mmi.12476 · Cited by 80
Single nucleotide polymorphisms in Mycobacterium tuberculosis and the need for a curated database
Stucki, D., & Gagneux, S. (2012) · Tuberculosis · doi:10.1016/j.tube.2012.11.002 · Cited by 61
Self-citationKambli, P., Ajbani, K., Sadani, M., Nikam, C., Shetty, A., Udwadia, Z. F., Rodwell, T. C., Catanzaro, A., & Rodrigues, C. S. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.11.003 · Cited by 42
Self-citationSalamon, H., Yamaguchi, K. D., Cirillo, D. M., Miotto, P., Schito, M. L., Posey, J. E., Starks, A. M., Niemann, S., Alland, D., Hanna, D. L., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu816 · Cited by 36
Self-citationReeves, A. Z., Campbell, P., Willby, M. J., & Posey, J. E. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04438-14 · Cited by 32
Self-citationCoeck, N., de Jong, B. C., Diels, M., de Rijk, P., Ardizzoni, E., Deun, A. V., & Rigouts, L. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv499 · Cited by 32
Self-citationRibosomal drug resistance in mycobacteria
Sander, P., Meier, A., & Böttger, E. C. (1996) · Research in Microbiology · doi:10.1016/0923-2508(96)80205-1 · Cited by 24
Cited by
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
The CRyPTIC Consortium and the 100, 0. G. P. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800474 · Cited by 500
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., Cattamanchi, A., Cegielski, J. P., Chen, L., Daley, C. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1874st · Cited by 462
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues
Meehan, C. J., Goig, G. A., Kohl, T. A., Verboven, L., Dippenaar, A., Ezewudo, M., Farhat, M. R., Guthrie, J. L., Laukens, K., Miotto, P., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0214-5 · Cited by 422
Self-citationGenome-Based Prediction of Bacterial Antibiotic Resistance
Su, M., Satola, S. W., & Read, T. D. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01405-18 · Cited by 369
Tuberculosis: advances and challenges in development of new diagnostics and biomarkers
Walzl, G., McNerney, R., du Plessis, N., Bates, M., McHugh, T. D., Chegou, N. N., & Zumla, A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30111-7 · Cited by 341
Self-citation
Metadata
- Authors
- Miotto, P., Tessema, B., Tagliani, E., Chindelevitch, L., Starks, A. M., Emerson, C., Hanna, D., Kim, P. S., Liwski, R., Zignol, M., Gilpin, C., Niemann, S., Denkinger, C. M., Fleming, J., Warren, R. M., Crook, D., Posey, J., Gagneux, S., Hoffner, S., Rodrigues, C., Comas, I., Engelthaler, D. M., Murray, M., Alland, D., Rigouts, L., Lange, C., Dheda, K., Hasan, R., Ranganathan, U. D. K., McNerney, R., Ezewudo, M., Cirillo, D. M., Schito, M., Köser, C. U., & Rodwell, T. C.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2017-12
- Volume
- 50
- Issue
- 6
- Pages
- 1701354
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2779510789
- Cited by
- 327
- References
- 40
- FWCI
- 28.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.